You can buy or sell VIVO and other stocks, options, ETFs, and crypto commission-free!
Meridian Bioscience, Inc. engages in the development, manufacture, sale, and distribution of diagnostic test kits, antigens, reagents, and related products. It operates through the Diagnostics and Life Science segment. Read More The Diagnostics segment consists testing platforms and technologies such as Isothermal DNA Amplification, Rapid Immunoassay, Enzyme-linked Immunoassay, and Anodic Stripping Voltammetry. The Life Science segment distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.
52 Week High
52 Week Low
Yahoo FinanceMay 9
Here’s What Hedge Funds Think About Meridian Bioscience, Inc.
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved, lost nearly 40% of its value at one point in 2018. Although hedge funds are not perfect, their consensus picks do deliver solid returns, however. Our data show the top 15 S&P 500 stocks among hedge funds at the end of December 2018 yielded an average return of 19.7% year-to-date, vs. a gain of 13.1% for the S&P 500 Index. Because hedge funds have a lot of resources and their consensus pi...
Yahoo FinanceMay 3
Edited Transcript of VIVO earnings conference call or presentation 30-Apr-19 2:00pm GMT
Q2 2019 Meridian Bioscience Inc Earnings Call CINCINNATI May 3, 2019 (Thomson StreetEvents) -- Edited Transcript of Meridian Bioscience Inc earnings conference call or presentation Tuesday, April 30, 2019 at 2:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Eric S. Rasmussen Meridian Bioscience, Inc. - Executive VP & CFO * J...
Current Valuation: Meridian Bioscience (NASDAQ: VIVO)
Meridian Bioscience trades as part of the healthcare sector and trades as part of the medical diagnostics and research industry. The company CEO is Jack P. Kenny. Meridian Bioscience Inc is an integrated life science company. It is engaged in development, manufacture, sale and distribution of diagnostic test kits for certain gastrointestinal, viral, respiratory and parasitic infectious diseases. Previous Intraday Trading Performance: The VIVO stock showed a previous change of 1.52% with an open at 11.80 a...
Expected Jul 30, Pre-Market